(Q85203904)

English

Secondary malignancies after allogeneic stem-cell transplantation in the era of reduced-intensity conditioning; the incidence is not reduced

scientific article published on 17 October 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23072778%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Secondary malignancies after allogeneic stem-cell transplantation in the era of reduced-intensity conditioning; the incidence is not reduced (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23072778%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

stem cell transplantation

1 reference

based on heuristic

inferred from title

author name string

A Shimoni

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23072778%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

N Shem-Tov

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23072778%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

A Chetrit

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23072778%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Y Volchek

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23072778%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

E Tallis

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23072778%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

A Avigdor

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23072778%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

S Sadetzki

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23072778%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

R Yerushalmi

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23072778%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

A Nagler

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23072778%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

publication date

17 October 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23072778%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23072778%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

27

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23072778%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23072778%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

829-835

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23072778%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Reduced mortality after allogeneic hematopoietic-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.299

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term survival and late deaths after allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.299

7 January 2021

based on heuristic

inferred from DOI database lookup

Solid cancers after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.299

7 January 2021

based on heuristic

inferred from DOI database lookup

Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.299

7 January 2021

based on heuristic

inferred from DOI database lookup

Solid cancers after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.299

7 January 2021

based on heuristic

inferred from DOI database lookup

Second solid cancers after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.299

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.299

7 January 2021

based on heuristic

inferred from DOI database lookup

Solid cancers after allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.299

7 January 2021

based on heuristic

inferred from DOI database lookup

Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.299

7 January 2021

based on heuristic

inferred from DOI database lookup

Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.299

7 January 2021

based on heuristic

inferred from DOI database lookup

Allo-SCT for AML and MDS with treosulfan compared with BU-based regimens: reduced toxicity vs reduced intensity

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.299

7 January 2021

based on heuristic

inferred from DOI database lookup

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.299

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.299

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms of therapy-related carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.299

7 January 2021

based on heuristic

inferred from DOI database lookup

Alloreactive microenvironment after human hematopoietic cell transplantation induces genomic alterations in epithelium through an ROS-mediated mechanism: in vivo and in vitro study and implications to secondary neoplasia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.299

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased risk of cervical dysplasia in long-term survivors of allogeneic stem cell transplantation--implications for screening and HPV vaccination

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.299

7 January 2021

based on heuristic

inferred from DOI database lookup

Cellular and clinical pharmacology of fludarabine

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.299

7 January 2021

based on heuristic

inferred from DOI database lookup

Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.299

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.299

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term outcome and late effects in patients transplanted with mobilised blood or bone marrow: a randomised trial.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.299

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.299

7 January 2021

based on heuristic

inferred from DOI database lookup

Skin cancer after nonmyeloablative hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.299

7 January 2021

based on heuristic

inferred from DOI database lookup

Donor Cell Leukemia: A Review

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.299

7 January 2021

based on heuristic

inferred from DOI database lookup

Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.299

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q85203904&oldid=2225255240"